Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

BDSX

Biodesix Inc

Dec 11 • 04:00PM ET

1.30

Dollar change -0.02
Percentage change -1.52	%

Healthcare • Diagnostics & Research • USA • NASD

Peers: ILMN BEAM CDNA FLGT GH EXAS QDEL TWST CRSP PACB

| Held by: VTI VXF IWC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.39	Insider Own	49.12%	Shs Outstand	145.47M	Perf Week	-3.70%
Market Cap	189.11M	Forward P/E	-	EPS next Y	-0.22	Insider Trans	0.89%	Shs Float	74.02M	Perf Month	-7.80%
Income	-43.82M	PEG	-	EPS next Q	-0.07	Inst Own	40.84%	Short Float	0.84%	Perf Quarter	-27.78%
Sales	65.56M	P/S	2.88	EPS this Y	45.63%	Inst Trans	13.09%	Short Ratio	1.51	Perf Half Y	-15.58%
Book/sh	0.19	P/B	6.79	EPS next Y	37.76%	ROA	-46.24%	Short Interest	0.62M	Perf Year	-18.24%
Cash/sh	0.22	P/C	6.00	EPS next 5Y	-	ROE	-331.82%	52W Range	1.11 - 2.21	Perf YTD	-29.35%
Dividend Est.	-	P/FCF	-	EPS past 5Y	8.42%	ROI	-49.15%	52W High	-41.18%	Beta	1.14
Dividend TTM	-	Quick Ratio	3.30	Sales past 5Y	24.79%	Gross Margin	77.72%	52W Low	17.12%	ATR (14)	0.10
Dividend Ex-Date	-	Current Ratio	3.40	EPS Y/Y TTM	56.19%	Oper. Margin	-52.71%	RSI (14)	41.72	Volatility	8.25% 7.72%
Employees	217	Debt/Eq	2.22	Sales Y/Y TTM	48.91%	Profit Margin	-66.84%	Recom	1.00	Target Price	3.10
Option/Short	Yes / Yes	LT Debt/Eq	2.20	EPS Q/Q	48.98%	Payout	-	Rel Volume	0.87	Prev Close	1.32
Sales Surprise	-2.24%	EPS Surprise	4.24%	Sales Q/Q	34.54%	Earnings	Nov 01 BMO	Avg Volume	414.17K	Price	1.30
SMA20	-2.46%	SMA50	-11.98%	SMA200	-15.51%	Trades		Volume	361,097	Change	-1.52%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-16-24	Initiated	Scotiabank	Sector Outperform
Jul-26-24	Initiated	Craig Hallum	Buy	$3
May-13-24	Initiated	TD Cowen	Buy	$2.80
May-03-24	Initiated	Lake Street	Buy	$3
Nov-17-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$21 → $11
Nov-23-20	Initiated	William Blair	Outperform
Nov-23-20	Initiated	Morgan Stanley	Overweight	$20
Nov-23-20	Initiated	Canaccord Genuity	Buy	$26
Nov-23-20	Initiated	BTIG Research	Buy	$22

Nov-20-24 09:35AM	Biodesix (BDSX) Loses -22.98% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Nov-02-24 03:01AM	Biodesix Inc (BDSX) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Operational ... (GuruFocus.com)
Nov-01-24 07:15AM	Biodesix, Inc. (BDSX) Reports Q3 Loss, Misses Revenue Estimates (Zacks) -23.53%
06:00AM	Biodesix Announces Third Quarter 2024 Results and Highlights (GlobeNewswire)
Oct-31-24 09:06AM	What To Expect From Biodesix Inc (BDSX) Q3 2024 Earnings (GuruFocus.com)
06:00AM	Loading…
Oct-29-24 06:00AM	Biodesix to Participate in Three Investor Conferences in November (GlobeNewswire)
Oct-18-24 06:00AM	Biodesix to Report Third Quarter 2024 Financial Results on November 1, 2024 (Business Wire)
Oct-07-24 06:00AM	Biodesix Announces New Data Presentation at CHEST 2024 Annual Meeting and the Launch of a Complementary Clinical Study (Business Wire)
Sep-05-24 06:00AM	Biodesix to Present at Two Investor Conferences in September (Business Wire)
Aug-08-24 10:23AM	Q2 2024 Biodesix Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-07-24 06:05PM	Biodesix, Inc. (BDSX) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:01PM	Biodesix Announces Second Quarter 2024 Results and Highlights (Business Wire)
Aug-06-24 06:00AM	Biodesix to Present at Canaccord Genuitys 44th Annual Growth Conference (Business Wire)
Jul-24-24 06:00AM	Biodesix to Report Second Quarter 2024 Financial Results on August 7, 2024 (Business Wire)
Jun-18-24 08:13AM	Biodesix Named to Inc. Magazine's 2024 "Best Workplaces" (Business Wire)
06:00AM	Loading…
May-28-24 06:00AM	Biodesix to Participate in Two Investor Conferences in June (Business Wire)
May-21-24 06:00AM	Biodesix to Present New Data on the Nodify XL2 Test at ATS 2024 Annual Meeting (Business Wire)
May-10-24 05:59PM	Biodesix, Inc. (NASDAQ:BDSX) Q1 2024 Earnings Call Transcript (Insider Monkey)
03:55PM	Biodesix Inc (BDSX) Surpasses Analyst Revenue Forecasts with Strong Q1 2024 Performance (GuruFocus.com)
May-09-24 03:46AM	Biodesix Inc (BDSX) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ... (GuruFocus.com)
May-08-24 09:00PM	BDSX Stock Earnings: Biodesix Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
05:20PM	Biodesix, Inc. (BDSX) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:01PM	Biodesix Announces First Quarter 2024 Results Driven by Growth in Lung Diagnostic Testing for Lung Nodule Management (Business Wire)
May-07-24 06:00AM	Biodesix to Participate in the 2024 RBCCM Global Healthcare Conference (Business Wire)
Apr-24-24 06:00AM	Biodesix to Report First Quarter 2024 Financial Results on May 8, 2024 (Business Wire)
Apr-09-24 05:00PM	Biodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual Meeting (Business Wire) -9.93%
Apr-05-24 07:17AM	Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement (Business Wire) -7.28%
Mar-25-24 06:00AM	Biodesix Announces New Master Collaborative Research Agreement with Leading US Cancer Center (Business Wire)
Mar-04-24 09:04AM	Biodesix, Inc. (NASDAQ:BDSX) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-01-24 10:40PM	Q4 2023 Biodesix Inc Earnings Call (Thomson Reuters StreetEvents)
06:31AM	Loading…
06:31AM	Biodesix Inc (BDSX) Reports Strong Growth in Lung Diagnostic Test Volume and Gross Profit Margin (GuruFocus.com)
06:00AM	Biodesix Announces Fourth Quarter and Fiscal Year 2023 Results and Business Highlights (Business Wire)
Feb-26-24 06:00AM	Biodesix to Participate in the TD Cowen 44th Annual Health Care Conference (Business Wire)
Feb-16-24 06:00AM	Biodesix to Report Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024 (Business Wire) -5.73%
Feb-13-24 03:00AM	Biodesix Inc CEO Scott Hutton Sells 64,390 Shares (GuruFocus.com)
Jan-26-24 09:04AM	3 Penny Stocks to Turn $999 Into $1 Million: January 2024 (InvestorPlace)
Nov-14-23 06:00AM	Biodesix Enhances Access to Nodify Lung Testing with Launch of New Blood Draw Method (Business Wire)
Nov-09-23 06:00AM	Biodesix to Participate in Two Upcoming Investor Conferences in November (Business Wire) -6.39%
Nov-07-23 04:01PM	Biodesix Announces Third Quarter 2023 Results and Highlights (Business Wire) -10.14%
Oct-24-23 06:00AM	Biodesix to Report Third Quarter 2023 Financial Results on November 7, 2023 (Business Wire) -5.00%
Oct-03-23 06:00AM	Biodesix to Present New Data on Nodify Lung® Testing at CHEST 2023 Annual Meeting (Business Wire)
Sep-07-23 06:00AM	Biodesix Announces Two Presentations on Lung Cancer Treatment Guidance Tests at the IASLC 2023 World Lung Conference on Lung Cancer (Business Wire)
Sep-05-23 06:00AM	Biodesix to Participate in Two Upcoming Investor Conferences in September (Business Wire) -11.76%
Aug-22-23 06:00AM	Biodesix Announces Presentation of New Nodify XL2® Data at AABIP Conference Highlighting Increased Proportion of Biopsies Diagnosing Cancer (Business Wire)
Aug-09-23 10:25AM	Biodesix, Inc. (NASDAQ:BDSX) Q2 2023 Earnings Call Transcript (Insider Monkey) -15.62%
Aug-08-23 08:38AM	Q2 2023 Biodesix Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-07-23 05:15PM	Biodesix, Inc. (BDSX) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:01PM	Biodesix Announces Second Quarter 2023 Results and Highlights (Business Wire)
Aug-01-23 06:00AM	Biodesix to Participate in the Canaccord Genuity 43rd Annual Growth Conference (Business Wire) +20.17%
Jul-26-23 07:58AM	Biodesix (NASDAQ:BDSX) investors are sitting on a loss of 49% if they invested a year ago (Simply Wall St.)
Jul-24-23 06:00AM	Biodesix to Report Second Quarter 2023 Financial Results on August 7, 2023 (Business Wire)
Jul-12-23 06:00AM	Biodesix Announces Publication of the ORACLE Clinical Utility Study with the Primary Endpoint Demonstrating that the Nodify XL2® Test Reduced Unnecessary Invasive Procedures on Benign Lung Nodules (Business Wire)
Jul-06-23 09:11AM	Biodesix Awarded Advanced Diagnostic Laboratory Test Status for its Nodify CDT® Test by the Center for Medicare and Medicaid Services (Business Wire)
Jun-27-23 06:00AM	Biodesix Completes Enrollment of INSIGHT Study Assessing Clinical Utility of the VeriStrat® Blood-Based Host Immune Classifier (Business Wire) -5.83%
Jun-01-23 06:00AM	Biodesix Announces Three Abstracts to Be Presented at ASCO 2023 Annual Meeting (Business Wire)
May-31-23 06:00AM	Biodesix to Participate in William Blairs 43rd Annual Growth Stock Conference (Business Wire)
May-28-23 08:09AM	Jack Schuler Spends US$65k On Biodesix Stock \ (Simply Wall St.)
May-25-23 06:00AM	Biodesix Announces Four Presentations of Health Economic Data Highlighting Cost Saving Potential of Nodify Lung® Testing (Business Wire) +5.30%
May-24-23 06:00AM	Biodesix, Inc. Chief Financial Officer Robin Harper Cowie Appointed to Colorado BioScience Association's Board of Directors (Business Wire) +12.68%
May-18-23 07:00AM	Biodesix Announces New Clinical Utility Evidence for the Nodify XL2® Nodule Risk Assessment Test to Be Presented at ATS 2023 International Conference (Business Wire) -5.79%
May-12-23 11:10AM	Q1 2023 Biodesix Inc Earnings Call (Thomson Reuters StreetEvents) -12.28%
May-11-23 05:25PM	Biodesix, Inc. (BDSX) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:01PM	Biodesix Announces First Quarter 2023 Results and Highlights (Business Wire)
May-09-23 06:15PM	Natera (NTRA) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
Apr-27-23 06:00AM	Biodesix to Report First Quarter 2023 Financial Results on May 11, 2023 (Business Wire)
Apr-12-23 06:53AM	Insiders of Biodesix, Inc. (NASDAQ:BDSX) must be frustrated after market cap dropped US$16m since recent purchases (Simply Wall St.)
Mar-15-23 09:31AM	Bullish Biodesix, Inc. (NASDAQ:BDSX) insiders filled their treasuries with US$34m worth of stock over last year (Simply Wall St.) +15.24%
Mar-08-23 07:14AM	Biodesix, Inc. (NASDAQ:BDSX) Q4 2022 Earnings Call Transcript (Insider Monkey) -5.06%
Mar-06-23 07:25AM	Biodesix, Inc. (BDSX) Reports Q4 Loss, Misses Revenue Estimates (Zacks) -10.00%
06:00AM	Biodesix Announces Fourth Quarter and Fiscal Year End 2022 Results and Highlights (Business Wire)
Feb-28-23 06:00AM	Biodesix to Participate at Cowens 43rd Annual Healthcare Conference (Business Wire)
Feb-21-23 06:00AM	Biodesix to Report Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023 (Business Wire)
Feb-16-23 06:27AM	Even after rising 15% this past week, Biodesix (NASDAQ:BDSX) shareholders are still down 39% over the past year (Simply Wall St.) +5.72%
Dec-19-22 06:00AM	Biodesix Announces First Four Private Payer Coverage Policies for the Nodify XL2® Test (Business Wire) +5.88%
Dec-16-22 04:01PM	Biodesix Announces Appointment of Lawrence (Lair) T. Kennedy, Jr. to Board of Directors (Business Wire)
Dec-12-22 06:00AM	Biodesix Ranked Top Proteomics Solutions Company by Life Sciences Review Magazine (Business Wire) +8.57%
Nov-21-22 04:01PM	Biodesix Announces Closing of Upsized Public Offering and Full Exercise of Option to Purchase Additional Shares (Business Wire) -7.14% +13.85%
Nov-17-22 12:26AM	Biodesix Announces Pricing of $35.1 Million Upsized Public Offering of Common Stock (Business Wire) +23.48%
Nov-16-22 04:05PM	Biodesix Announces Proposed Public Offering of Common Stock (Business Wire) +8.49%
04:01PM	Biodesix Announces Senior Secured Financing Agreement with Perceptive Advisors for Up to $50 Million (Business Wire)
Nov-10-22 09:00AM	Biodesix Presents New Data from the INSIGHT Study at the 2022 Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting (Business Wire)
Nov-09-22 05:33AM	Biodesix Third Quarter 2022 Earnings: Revenues Beat Expectations, EPS Lags (Simply Wall St.) -6.42%
Nov-03-22 07:15AM	Biodesix, Inc. (BDSX) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
06:00AM	Biodesix Announces Third Quarter 2022 Results and Highlights (Business Wire)
Oct-20-22 06:00AM	Biodesix to Report Third Quarter 2022 Financial Results on November 3, 2022 (Business Wire)
Oct-17-22 05:05PM	Boulder's Biodesix snags $20M contract, plans move to larger space in Louisville (American City Business Journals)
06:00AM	Biodesix Awarded U.S. Federal Supply Schedule Contract for Its Comprehensive Lung Cancer Diagnostic Testing Solutions (Business Wire)
Oct-12-22 06:00AM	Biodesix to Present Data at the CHEST 2022 Annual Meeting Demonstrating High Sensitivity of the Nodify XL2® Blood-Based Lung Nodule Test in Various Patient Populations, Including Individuals Participating in Lung Cancer Screening Programs (Business Wire) -7.09%
Oct-11-22 06:00AM	Biodesix Announces Preliminary Revenue for Third Quarter 2022 (Business Wire)
Sep-06-22 06:00AM	Biodesix to Participate in Two Upcoming Investor Conferences in September (Business Wire) -6.56%
Aug-09-22 06:00AM	Biodesix Named a Top 100 Healthcare Technology Company of 2022 (Business Wire) -13.62%
Aug-06-22 04:30AM	Biodesix, Inc. (BDSX) Q2 2022 Earnings Call Transcript (Motley Fool)
Aug-04-22 07:15AM	Biodesix, Inc. (BDSX) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
06:00AM	Biodesix Announces Second Quarter 2022 Results and Highlights (Business Wire)
Aug-03-22 06:00AM	Biodesix to Present at the Canaccord Genuity 42nd Annual Growth Conference (Business Wire) +5.34%
Jul-30-22 10:44AM	Biodesix, Inc. (NASDAQ:BDSX) insiders placed bullish bets worth US$21m in the last 12 months (Simply Wall St.)
Jul-20-22 06:00AM	Biodesix to Present Data at IASLC 2022 World Conference Demonstrating that the VeriStrat® Test is Predictive of Progression Free Survival and Overall Survival in Patients with Low or Negative PD-L1 Treated with Immune Checkpoint Inhibitors (Business Wire)
Jul-19-22 06:00AM	Biodesix to Report Second Quarter 2022 Financial Results on August 4, 2022 (Business Wire)
Jun-22-22 09:19AM	Sotera Health Company (SHC) Stock Jumps 6.5%: Will It Continue to Soar? (Zacks)
Jun-15-22 10:11AM	Investors in Biodesix (NASDAQ:BDSX) have unfortunately lost 90% over the last year (Simply Wall St.)

Biodesix, Inc. provides blood-based diagnostics services for patients with lung disease. The firm offers GeneStrat, a genomic blood test for patients who have been diagnosed with advanced lung cancer and VeriStrat, a serum proteomic test that provides prognostic and predictive information for patients with non-small cell lung cancer. It also offers six diagnostic tests including: Nodify XL2, Nodify CDT, GeneStrat, VeriStrat, Bio-Rad SARS-CoV-2 ddPCR test and the Platelia SARS-CoV-2 test. The company was founded by David Brunel and Robert E. Cawthorn in 2005 and is headquartered in Louisville, CO.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
SCHULER JACK W	Director	Nov 21 '24	Buy	1.23	100,000	122,840	31,194,935	Nov 22 12:30 PM
Kennedy Lawrence T. Jr	Director	Nov 21 '24	Buy	1.16	35,000	40,562	10,411,024	Nov 22 12:30 PM
SCHULER JACK W	Director	Nov 20 '24	Buy	1.17	200,000	234,000	31,094,935	Nov 21 03:30 PM
Vazquez Chris	Chief Accounting Officer	Nov 11 '24	Sale	1.39	105	146	11,685	Nov 13 04:22 PM
Vazquez Chris	Chief Accounting Officer	Nov 12 '24	Sale	1.40	98	137	11,587	Nov 13 04:22 PM
Pestano Gary Anthony	Chief Development Officer	Nov 11 '24	Sale	1.39	220	306	127,234	Nov 13 04:22 PM
Pestano Gary Anthony	Chief Development Officer	Nov 12 '24	Sale	1.40	207	290	127,027	Nov 13 04:22 PM
O'Kane Kieran	Chief Commercial Officer	Nov 11 '24	Sale	1.39	238	331	97,672	Nov 13 04:21 PM
O'Kane Kieran	Chief Commercial Officer	Nov 12 '24	Sale	1.40	224	314	97,448	Nov 13 04:21 PM
Hutton Scott	President & CEO	Nov 11 '24	Sale	1.39	1,927	2,680	534,792	Nov 13 04:21 PM
Hutton Scott	President & CEO	Nov 12 '24	Sale	1.40	1,813	2,540	532,979	Nov 13 04:21 PM
Cowie Robin Harper	CFO, Sec'y & Treasurer	Nov 11 '24	Sale	1.39	500	695	203,807	Nov 13 04:21 PM
Cowie Robin Harper	CFO, Sec'y & Treasurer	Nov 12 '24	Sale	1.40	471	660	203,336	Nov 13 04:21 PM
Strobeck Matthew	Director	Nov 05 '24	Buy	1.40	40,000	55,916	2,606,879	Nov 06 03:16 PM
SCHULER JACK W	Director	Nov 05 '24	Buy	1.36	100,253	136,585	30,894,935	Nov 06 03:16 PM
PATIENCE JOHN	Chairman	Nov 05 '24	Buy	1.38	75,000	103,710	2,153,298	Nov 06 03:16 PM
MASSARANY HANY	Director	Nov 05 '24	Buy	1.37	22,500	30,865	53,364	Nov 06 03:15 PM
Kennedy Lawrence T. Jr	Director	Nov 05 '24	Buy	1.36	51,200	69,888	10,356,024	Nov 06 03:15 PM
Kennedy Lawrence T. Jr	Director	Nov 06 '24	Buy	1.36	20,000	27,180	10,376,024	Nov 06 03:15 PM
Vazquez Chris	Chief Accounting Officer	Aug 09 '24	Sale	1.60	155	248	11,242	Aug 12 07:24 PM
Vazquez Chris	Chief Accounting Officer	Aug 12 '24	Sale	1.57	54	85	11,188	Aug 12 07:24 PM
Pestano Gary Anthony	Chief Development Officer	Aug 09 '24	Sale	1.60	320	512	126,187	Aug 12 07:24 PM
Pestano Gary Anthony	Chief Development Officer	Aug 12 '24	Sale	1.57	111	174	126,076	Aug 12 07:24 PM
O'Kane Kieran	Chief Commercial Officer	Aug 09 '24	Sale	1.60	345	552	89,748	Aug 12 07:24 PM
O'Kane Kieran	Chief Commercial Officer	Aug 12 '24	Sale	1.57	120	189	89,628	Aug 12 07:24 PM
Hutton Scott	President & CEO	Aug 09 '24	Sale	1.60	2,781	4,452	519,331	Aug 12 07:23 PM
Hutton Scott	President & CEO	Aug 12 '24	Sale	1.57	963	1,514	518,368	Aug 12 07:23 PM
Cowie Robin Harper	CFO, Sec'y & Treasurer	Aug 09 '24	Sale	1.60	724	1,159	191,402	Aug 12 07:23 PM
Cowie Robin Harper	CFO, Sec'y & Treasurer	Aug 12 '24	Sale	1.57	251	395	191,151	Aug 12 07:23 PM
Cowie Robin Harper	CFO, Sec'y & Treasurer	May 21 '24	Option Exercise	0.42	4,209	1,768	175,889	May 23 07:13 PM
Vazquez Chris	Chief Accounting Officer	May 09 '24	Sale	1.48	244	361	9,915	May 10 05:06 PM
Pestano Gary Anthony	Chief Development Officer	May 09 '24	Sale	1.48	434	642	124,248	May 10 05:06 PM
O'Kane Kieran	Chief Commercial Officer	May 09 '24	Sale	1.48	468	692	75,524	May 10 05:05 PM
Hutton Scott	President & CEO	May 09 '24	Sale	1.48	3,764	5,569	483,780	May 10 05:04 PM
Cowie Robin Harper	CFO, Sec'y & Treasurer	May 09 '24	Sale	1.48	980	1,450	171,680	May 10 05:04 PM
Vazquez Chris	Chief Accounting Officer	Feb 09 '24	Sale	1.92	1,077	2,064	10,470	Feb 12 09:46 PM
Vazquez Chris	Chief Accounting Officer	Feb 12 '24	Sale	1.66	922	1,535	9,548	Feb 12 09:46 PM
Pestano Gary Anthony	Chief Development Officer	Feb 09 '24	Sale	1.92	5,862	11,235	128,272	Feb 12 09:45 PM
Pestano Gary Anthony	Chief Development Officer	Feb 12 '24	Sale	1.66	5,022	8,360	123,250	Feb 12 09:45 PM
O'Kane Kieran	Chief Commercial Officer	Feb 09 '24	Sale	1.92	6,319	12,111	73,417	Feb 12 09:45 PM
O'Kane Kieran	Chief Commercial Officer	Feb 12 '24	Sale	1.66	5,412	9,009	68,005	Feb 12 09:45 PM
Hutton Scott	President & CEO	Feb 09 '24	Sale	1.92	34,682	66,472	494,719	Feb 12 09:45 PM
Hutton Scott	President & CEO	Feb 12 '24	Sale	1.66	29,708	49,455	465,011	Feb 12 09:45 PM
Cowie Robin Harper	CFO, Sec'y & Treasurer	Feb 09 '24	Sale	1.92	10,156	19,465	178,109	Feb 12 09:44 PM
Cowie Robin Harper	CFO, Sec'y & Treasurer	Feb 12 '24	Sale	1.66	8,699	14,481	169,410	Feb 12 09:44 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BDSX

Biodesix Inc

Upgrade your FINVIZ experience